BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35643579)

  • 1. Potential competing risk of death in older high-risk endometrial carcinoma patients: Results from a multicentric retrospective cohort.
    Gorgeu V; Borghese B; Koual M; Just PA; Lefrere Belda MA; Delanoy N; Durdux C; Chapron C; Goldwasser F; Gervais C; Blons H; Terris B; Badoual C; Taly V; Laurent-Puig P; Bats AS; Alexandre J; Beinse G
    Gynecol Oncol; 2022 Aug; 166(2):269-276. PubMed ID: 35643579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
    Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
    Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast Cancer.
    Derks MGM; van de Velde CJH; Giardiello D; Seynaeve C; Putter H; Nortier JWR; Dirix LY; Bastiaannet E; Portielje JEA; Liefers GJ
    Oncologist; 2019 Jul; 24(7):e467-e474. PubMed ID: 30606886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-Adjusted Charlson Comorbidity Index Predicts Survival in Endometrial Cancer Patients.
    Di Donato V; D'Oria O; Giannini A; Bogani G; Fischetti M; Santangelo G; Tomao F; Palaia I; Perniola G; Muzii L; Benedetti Panici P
    Gynecol Obstet Invest; 2022; 87(3-4):191-199. PubMed ID: 35793638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Comorbidity on the Risk of Death: A Single Institution Study of 1132 Women With Early-stage Uterine Cancer.
    Elshaikh MA; Vance S; Kamal M; Burmeister C; Hanna RK; Rasool N; Siddiqui F
    Am J Clin Oncol; 2017 Apr; 40(2):183-188. PubMed ID: 25222075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a RNAseq signature for prognostic stratification in endometrial cancer.
    Beinse G; Le Frere Belda MA; Just PA; Bekmezian N; Koual M; Garinet S; Leroy K; Letourneur F; Lusson A; Mulot C; Le Corre D; Metairie M; Delanoy N; Blons H; Gervais C; Durdux C; Chapron C; Goldwasser F; Terris B; Badoual C; Taly V; Laurent-Puig P; Borghese B; Bats AS; Alexandre J
    Gynecol Oncol; 2022 Mar; 164(3):596-606. PubMed ID: 35033379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
    Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
    Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validated competing event model for the stage I-II endometrial cancer population.
    Carmona R; Gulaya S; Murphy JD; Rose BS; Wu J; Noticewala S; McHale MT; Yashar CM; Vaida F; Mell LK
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):888-98. PubMed ID: 24969798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of age-adjusted Charlson comorbidity score on outcomes for patients with early-stage endometrial cancer.
    Robbins JR; Gayar OH; Zaki M; Mahan M; Buekers T; Elshaikh MA
    Gynecol Oncol; 2013 Dec; 131(3):593-7. PubMed ID: 24125752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article).
    Chen JR; Chang TC; Fu HC; Lau HY; Chen IH; Ke YM; Liang YL; Chiang AJ; Huang CY; Chen YC; Hong MK; Wang YC; Huang KF; Hsiao SM; Wang PH
    Medicine (Baltimore); 2016 Apr; 95(15):e3330. PubMed ID: 27082583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Age-Adjusted Charlson Comorbidity Score Impact Survival Endpoints in Women with Federation of Gynecology and Obstetrics-Stage III Endometrial Cancer?
    Ghanem AI; Modh A; Burmeister C; Munkarah AR; Elshaikh MA
    Gynecol Obstet Invest; 2018; 83(3):290-298. PubMed ID: 29518778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cause-Specific Survival After Meningioma Surgery: A Nationwide Population-Based Competing Risk Study.
    Champeaux-Depond C; Constantinou P; Weller J
    World Neurosurg; 2021 Feb; 146():e67-e75. PubMed ID: 33096279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index, diabetes and survival after diagnosis of endometrial cancer: A report from the HUNT-Survey.
    Lindemann K; Cvancarova M; Eskild A
    Gynecol Oncol; 2015 Dec; 139(3):476-80. PubMed ID: 26434365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of
    Beinse G; Rance B; Just PA; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Batteux F; Durdux C; Chapron C; Pasmant E; Leroy K; Alexandre J; Borghese B
    Int J Gynecol Cancer; 2020 May; 30(5):640-647. PubMed ID: 32169874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer.
    AlHilli MM; Mariani A; Bakkum-Gamez JN; Dowdy SC; Weaver AL; Peethambaram PP; Keeney GL; Cliby WA; Podratz KC
    Gynecol Oncol; 2014 Jun; 133(3):485-93. PubMed ID: 24690476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I Versus Type II Endometrial Cancer: Differential Impact of Comorbidity.
    Noer MC; Antonsen SL; Ottesen B; Christensen IJ; Høgdall C
    Int J Gynecol Cancer; 2018 Mar; 28(3):586-593. PubMed ID: 29303936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Older Age and Comorbidity on Locoregional and Distant Breast Cancer Recurrence: A Large Population-Based Study.
    de Boer AZ; van der Hulst HC; de Glas NA; Marang-van de Mheen PJ; Siesling S; de Munck L; de Ligt KM; Portielje JEA; Bastiaannet E; Liefers GJ
    Oncologist; 2020 Jan; 25(1):e24-e30. PubMed ID: 31515242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer.
    Nagle CM; Crosbie EJ; Brand A; Obermair A; Oehler MK; Quinn M; Leung Y; Spurdle AB; Webb PM;
    Gynecol Oncol; 2018 Jul; 150(1):99-105. PubMed ID: 29706522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data, intelligence platform-based analysis.
    Huang XD; Zhou GQ; Lv JW; Zhou HQ; Zhong CW; Wu CF; Zheng ZQ; He XJ; Peng L; Ma J; Sun Y
    Radiother Oncol; 2018 Nov; 129(2):389-395. PubMed ID: 30270098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competing Causes of Death in Older Adults with Thyroid Cancer.
    Papaleontiou M; Norton EC; Reyes-Gastelum D; Banerjee M; Haymart MR
    Thyroid; 2021 Sep; 31(9):1359-1365. PubMed ID: 33764188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.